Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Airgraft Inc. currently manages 1 pending office action within the Chemistry & Materials technology area. This 1 active matter is assigned to 1 distinct examiner working within 1 distinct art unit. The concentration of the portfolio under 1 examiner suggests a highly focused prosecution path for the company at this stage.
The busiest examiner for the portfolio is DIYAN, OLUWATOSIN OLUWATUMININ, who is responsible for 1 pending office action. This figure represents the company's current pending workload. Because the portfolio is distributed across 1 distinct art unit, the examiner's specific internal policies and historical trends will likely dictate the immediate outcomes for the pending application.
Practitioners should note that with 1 distinct examiner handling the pending matter, the prosecution strategy is dependent on the interactions with DIYAN, OLUWATOSIN OLUWATUMININ. The alignment of the Chemistry & Materials technology area with the current filings indicates that the intellectual property focus is concentrated. Future filings may expand these metrics, but the current data shows a centralized point of contact within the patent office.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DIYAN, OLUWATOSIN OLUWATUMININ | 1 | 27.3% | +54.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18373056 | METHODS AND SYSTEMS FOR VARIABLE-VISCOSITY CARRIER VAPORIZERS | DIYAN, OLUWATOSIN OLUWATUMININ | 26d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18373056 | METHODS AND SYSTEMS FOR VARIABLE-VISCOSITY CARRIER VAPORIZERS | DIYAN, OLUWATOSIN OLUWATUMININ | 26d |
| Art Unit | Apps |
|---|---|
| 1755 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18373056 | METHODS AND SYSTEMS FOR VARIABLE-VISCOSITY CARRIER VAPORIZERS | DIYAN, OLUWATOSIN OLUWATUMININ | 1755 | §103 | Final Rejection | 26d | Pending | Sep 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAirgraft Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Oluwatosin Oluwatuminin Diyan has the most, with 1 of Airgraft Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.